Zhang, Pei-Lin <br/><br/>
Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein.  [electronic resource] 

 -  Molecular and cellular neurosciences  Mar 2006 
 - 387-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1044-7431 
<br/><br/><label>Standard No.: </label>10.1016/j.mcn.2005.10.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calcium-Binding Proteins<br/>Cell Culture Techniques--methods<br/>Cell Differentiation--drug effects<br/>Cell Line<br/>Cell Shape--drug effects<br/>Down-Regulation--physiology<br/>Interleukin-6--genetics<br/>Intracellular Signaling Peptides and Proteins<br/>Mice<br/>Mice, Neurologic Mutants<br/>Molecular Sequence Data<br/>Myelin Basic Protein--drug effects<br/>Myelin Sheath--drug effects<br/>Nerve Growth Factors--drug effects<br/>Nerve Regeneration--drug effects<br/>Oligodendroglia--drug effects<br/>Organ Culture Techniques<br/>Receptors, Interleukin-6--genetics<br/>Recombinant Fusion Proteins--pharmacology<br/>Stathmin<br/>Stem Cell Transplantation--methods<br/>Stem Cells--drug effects<br/>Up-Regulation--drug effects